395 related articles for article (PubMed ID: 22723521)
21. Altered expression of genes controlling metabolism characterizes the tissue response to immune injury in lupus.
Kingsmore KM; Bachali P; Catalina MD; Daamen AR; Heuer SE; Robl RD; Grammer AC; Lipsky PE
Sci Rep; 2021 Jul; 11(1):14789. PubMed ID: 34285256
[TBL] [Abstract][Full Text] [Related]
22. Micro-RNA analysis of renal biopsies in human lupus nephritis demonstrates up-regulated miR-422a driving reduction of kallikrein-related peptidase 4.
Krasoudaki E; Banos A; Stagakis E; Loupasakis K; Drakos E; Sinatkas V; Zampoulaki A; Papagianni A; Iliopoulos D; Boumpas DT; Bertsias GK
Nephrol Dial Transplant; 2016 Oct; 31(10):1676-86. PubMed ID: 26546590
[TBL] [Abstract][Full Text] [Related]
23. The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice.
Sitrin J; Suto E; Wuster A; Eastham-Anderson J; Kim JM; Austin CD; Lee WP; Behrens TW
J Immunol; 2017 Aug; 199(4):1238-1249. PubMed ID: 28696253
[TBL] [Abstract][Full Text] [Related]
24. Cross-species transcriptome analysis for early detection and specific therapeutic targeting of human lupus nephritis.
Frangou E; Garantziotis P; Grigoriou M; Banos A; Nikolopoulos D; Pieta A; Doumas SA; Fanouriakis A; Hatzioannou A; Manolakou T; Alissafi T; Verginis P; Athanasiadis E; Dermitzakis E; Bertsias G; Filia A; Boumpas DT
Ann Rheum Dis; 2022 Oct; 81(10):1409-1419. PubMed ID: 35906002
[TBL] [Abstract][Full Text] [Related]
25. Podocyte-associated mRNA profiles in kidney tissue and in urine of patients with active lupus nephritis.
dos Santos M; Bringhenti RN; Rodrigues PG; do Nascimento JF; Pereira SV; Zancan R; Monticielo OA; Gasparin AA; de Castro WP; Veronese FV
Int J Clin Exp Pathol; 2015; 8(5):4600-13. PubMed ID: 26191151
[TBL] [Abstract][Full Text] [Related]
26. Intrarenal macrophage infiltration induced by T cells is associated with podocyte injury in lupus nephritis patients.
Ma R; Jiang W; Li Z; Sun Y; Wei Z
Lupus; 2016 Dec; 25(14):1577-1586. PubMed ID: 27147620
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-16 directly binds to DEC2 and inactivates the TLR4 signaling pathway to inhibit lupus nephritis-induced kidney tissue hyperplasia and mesangial cell proliferation.
Qi H; Cao Q; Liu Q
Int Immunopharmacol; 2020 Nov; 88():106859. PubMed ID: 32795896
[TBL] [Abstract][Full Text] [Related]
28. Intrarenal activation of adaptive immune effectors is associated with tubular damage and impaired renal function in lupus nephritis.
Pamfil C; Makowska Z; De Groof A; Tilman G; Babaei S; Galant C; Montigny P; Demoulin N; Jadoul M; Aydin S; Lesche R; McDonald F; Houssiau FA; Lauwerys BR
Ann Rheum Dis; 2018 Dec; 77(12):1782-1789. PubMed ID: 30065042
[TBL] [Abstract][Full Text] [Related]
29. Immune Cell Landscape Identification Associates Intrarenal Mononuclear Phagocytes With Onset and Remission of Lupus Nephritis in NZB/W Mice.
Li B; Tang Y; Ni X; Chen W
Front Genet; 2020; 11():577040. PubMed ID: 33304383
[TBL] [Abstract][Full Text] [Related]
30. Complement 1q protects MRL/lpr mice against lupus nephritis via inhibiting the nuclear factor-κB pathway.
Sun J; Guo S; Niu F; Liu D; Zhuang Y
Mol Med Rep; 2020 Dec; 22(6):5436-5443. PubMed ID: 33173997
[TBL] [Abstract][Full Text] [Related]
31. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome.
Su B; Ye H; You X; Ni H; Chen X; Li L
Life Sci; 2018 Sep; 208():26-32. PubMed ID: 30146016
[TBL] [Abstract][Full Text] [Related]
32. Punicalagin Ameliorates Lupus Nephritis via Inhibition of PAR2.
Seo Y; Mun CH; Park SH; Jeon D; Kim SJ; Yoon T; Ko E; Jo S; Park YB; Namkung W; Lee SW
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32674502
[TBL] [Abstract][Full Text] [Related]
33. The SLAM family member CD48 (Slamf2) protects lupus-prone mice from autoimmune nephritis.
Koh AE; Njoroge SW; Feliu M; Cook A; Selig MK; Latchman YE; Sharpe AH; Colvin RB; Paul E
J Autoimmun; 2011 Aug; 37(1):48-57. PubMed ID: 21561736
[TBL] [Abstract][Full Text] [Related]
34. Pathogenic role of NF-kappaB activation in tubulointerstitial inflammatory lesions in human lupus nephritis.
Zheng L; Sinniah R; Hsu SI
J Histochem Cytochem; 2008 May; 56(5):517-29. PubMed ID: 18285351
[TBL] [Abstract][Full Text] [Related]
35. Microthrombotic Renal Vascular Lesions Are Associated to Increased Renal Inflammatory Infiltration in Murine Lupus Nephritis.
Gonzalo-Gil E; García-Herrero C; Toldos O; Usategui A; Criado G; Pérez-Yagüe S; Barber DF; Pablos JL; Galindo M
Front Immunol; 2018; 9():1948. PubMed ID: 30210500
[No Abstract] [Full Text] [Related]
36. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
[TBL] [Abstract][Full Text] [Related]
37. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
38. Dependence of Glomerulonephritis Induction on Novel Intraglomerular Alternatively Activated Bone Marrow-Derived Macrophages and Mac-1 and PD-L1 in Lupus-Prone NZM2328 Mice.
Sung SJ; Ge Y; Dai C; Wang H; Fu SM; Sharma R; Hahn YS; Yu J; Le TH; Okusa MD; Bolton WK; Lawler JR
J Immunol; 2017 Apr; 198(7):2589-2601. PubMed ID: 28219886
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanisms governing the progression of nephritis in lupus prone mice and human lupus patients.
Daamen AR; Wang H; Bachali P; Shen N; Kingsmore KM; Robl RD; Grammer AC; Fu SM; Lipsky PE
Front Immunol; 2023; 14():1147526. PubMed ID: 36936908
[TBL] [Abstract][Full Text] [Related]
40. Expression of DNA topoisomerases in chronic proliferative kidney disease.
Ivanova LV; Rudolph P; Kellner U; Jürgensen A; Tareeva IE; Alm P; Proppe D
Kidney Int; 2000 Oct; 58(4):1603-12. PubMed ID: 11012894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
